{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:23:49Z","timestamp":1784301829531,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dr. Margaret Becklake Fellowship in Respiratory Research"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fonds de Recherche du Qu\u00e9bec en Sant\u00e9"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer resection is curative but associated with postoperative morbidity and mortality. This study evaluated whether elevated blood eosinophil count (BEC) was associated with postoperative outcomes in early-stage lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of consecutive adult patients undergoing lung resection for stage I and II non-small cell lung cancer in a large tertiary referral center from September 2017 to June 2021. Data were drawn from the institution\u2019s Data Warehouse. The primary outcome was 90-day healthcare utilization defined as emergency department visit or hospital readmission. Secondary outcomes were postoperative complications, index hospitalization length of stay, and 1-year survival. Preoperative 90-day BEC was categorized by a threshold of 200 cells\/\u00b5L. Covariates were age, sex, smoking status, Charlson Comorbidity Index, chronic obstructive pulmonary disease (COPD), asthma, tumor size, nodal status, surgical approach, and blood results (white blood cells, hemoglobin, and creatinine). The main analyses were validated by a second international cohort. Log-Poisson with robust variance estimation and Cox proportional hazards regression models were fit for primary and secondary outcomes. Analyses were replicated for BEC thresholds of 150 and 300 cells\/\u00b5L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 715 patients undergoing lung resection (median age\u2009=\u200969 years, 42% male, 29% with COPD), 146 patients (20%) had high preoperative BEC\u2009\u2265\u2009200 cells\/\u00b5L. BEC\u2009\u2265\u2009200 cells\/\u00b5L was associated with a higher rate of 90-day healthcare utilization:19% vs. 14% for BEC\u2009&lt;\u2009200 cells\/\u00b5L. This association remained after adjustment (Risk Ratio [RR], 1.52; 95% Confidence Interval [CI], 1.02\u20132.25) and the validation cohort (RR, 2.23; 95% CI, 1.06\u20134.69). BEC as a continuous measure was also associated with the primary outcome in both cohorts: RR, 2.15 (95% CI, 1.49\u20133.12) and RR, 1.42 (95% CI, 1.10\u20131.94), respectively. BEC\u2009\u2265\u2009200 cells\/\u00b5L was associated with higher probability of death 1 year post-surgery (adjusted Hazard Ratio, 2.41; 95% CI, 1.08\u20135.35). There was no difference in the risk of postoperative pulmonary complications between high and low BEC (RR, 0.86; 95% CI, 0.58\u20131.27).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated preoperative BEC was associated with higher risk of postoperative healthcare utilization and lower 1-year survival after lung cancer resection among patients with or without respiratory disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03672-9","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:15:31Z","timestamp":1777608931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood eosinophil counts and postoperative outcomes in early-stage lung cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Everglad","family":"Mugutso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pitrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan-Rapha\u00ebl","family":"Stetco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kutzkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bar-Shai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"5","key":"3672_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.20892\/j.issn.2095-3941.2021.0690","volume":"19","author":"C Li","year":"2022","unstructured":"Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R, et al. Advances in lung cancer screening and early detection. Cancer Biol Med. 2022;19(5):591\u2013608.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"3672_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cger.2015.08.008","volume":"32","author":"A Gajra","year":"2016","unstructured":"Gajra A, Akbar SA, Din NU. Management of Lung Cancer in the Elderly. Clin Geriatr Med. 2016;32(1):81\u201395.","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"3672_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1378\/chest.129.5.1305","volume":"129","author":"RS Loganathan","year":"2006","unstructured":"Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129(5):1305\u201312.","journal-title":"Chest"},{"issue":"2","key":"3672_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1183\/09031936.00144208","volume":"34","author":"RP Young","year":"2009","unstructured":"Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380\u20136.","journal-title":"Eur Respir J"},{"key":"3672_CR5","doi-asserted-by":"publisher","first-page":"147997312092543","DOI":"10.1177\/1479973120925430","volume":"17","author":"E Roy","year":"2020","unstructured":"Roy E, Rheault J, Pigeon MA, Ugalde PA, Racine C, Simard S, et al. Lung cancer resection and postoperative outcomes in COPD: A single-center experience. Chron Respir Dis. 2020;17:1479973120925430.","journal-title":"Chron Respir Dis"},{"issue":"6","key":"3672_CR6","first-page":"414","volume":"95","author":"C Mouronte-Roib\u00e1s","year":"2018","unstructured":"Mouronte-Roib\u00e1s C, Leiro-Fern\u00e1ndez V, Ruano-Ravi\u00f1a A, Ramos-Hern\u00e1ndez C, Abal-Arca J, Parente-Lamelas I, et al. Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization. Respir Int Rev Thorac Dis. 2018;95(6):414\u201321.","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"7","key":"3672_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1513\/AnnalsATS.201911-857OC","volume":"17","author":"M Ruparel","year":"2020","unstructured":"Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, et al. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort. Ann Am Thorac Soc. 2020;17(7):869\u201378.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"3672_CR8","first-page":"313","volume":"18","author":"M Garc\u00eda-Pardo","year":"2023","unstructured":"Garc\u00eda-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2023;18(3):313\u201323.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"5","key":"3672_CR9","doi-asserted-by":"publisher","first-page":"e0251886","DOI":"10.1371\/journal.pone.0251886","volume":"16","author":"JR Goffin","year":"2021","unstructured":"Goffin JR, Corriveau S, Tang GH, Pond GR. Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system. PLoS ONE. 2021;16(5):e0251886.","journal-title":"PLoS ONE"},{"issue":"7","key":"3672_CR10","first-page":"1079","volume":"24","author":"KMM Islam","year":"2015","unstructured":"Islam KMM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and Survival in Lung Cancer Patients. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2015;24(7):1079\u201385.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"3","key":"3672_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.23736\/S0026-4806.22.07962-9","volume":"113","author":"F Perrotta","year":"2022","unstructured":"Perrotta F, D\u2019Agnano V, Scial\u00f2 F, Komici K, Allocca V, Nucera F, et al. Evolving concepts in COPD and lung cancer: a narrative review. Minerva Med. 2022;113(3):436\u201348.","journal-title":"Minerva Med"},{"issue":"4","key":"3672_CR12","doi-asserted-by":"publisher","first-page":"2300239","DOI":"10.1183\/13993003.00239-2023","volume":"61","author":"A Agust\u00ed","year":"2023","unstructured":"Agust\u00ed A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239.","journal-title":"Eur Respir J"},{"key":"3672_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/COPD.S346591","volume":"17","author":"H Whittaker","year":"2022","unstructured":"Whittaker H, Rubino A, M\u00fcllerov\u00e1 H, Morris T, Varghese P, Xu Y, et al. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis. 2022;17:427\u201337.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"3672_CR14","first-page":"15","volume":"85","author":"RHJ Slenter","year":"2013","unstructured":"Slenter RHJ, Sprooten RTM, Kotz D, Wesseling G, Wouters EFM, Rohde GGU. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respir Int Rev Thorac Dis. 2013;85(1):15\u201326.","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"1","key":"3672_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","volume":"13","author":"S Ramakrishnan","year":"2025","unstructured":"Ramakrishnan S, Russell REK, Mahmood HR, Krassowska K, Melhorn J, Mwasuku C, et al. Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial. Lancet Respir Med. 2025;13(1):59\u201368.","journal-title":"Lancet Respir Med"},{"key":"3672_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/COPD.S4854","volume":"4","author":"E Bathoorn","year":"2009","unstructured":"Bathoorn E, Liesker JJW, Postma DS, Ko\u00ebter GH, van der Toorn M, van der Heide S, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis. 2009;4:101\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"3672_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3672_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-019-1268-7","volume":"21","author":"TH Harries","year":"2020","unstructured":"Harries TH, Rowland V, Corrigan CJ, Marshall IJ, McDonnell L, Prasad V, et al. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res. 2020;21(1):3.","journal-title":"Respir Res"},{"issue":"1","key":"3672_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, et al. Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2012;186(1):48\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3672_CR20","doi-asserted-by":"publisher","first-page":"2000838","DOI":"10.1183\/13993003.00838-2020","volume":"57","author":"WC Tan","year":"2021","unstructured":"Tan WC, Bourbeau J, Nadeau G, Wang W, Barnes N, Landis SH, et al. High eosinophil counts predict decline in FEV1: results from the CanCOLD study. Eur Respir J. 2021;57(5):2000838.","journal-title":"Eur Respir J"},{"issue":"18","key":"3672_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"DA Lipson","year":"2018","unstructured":"Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018;378(18):1671\u201380.","journal-title":"N Engl J Med"},{"issue":"5","key":"3672_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","volume":"203","author":"FJ Martinez","year":"2021","unstructured":"Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C, et al. Reduced All-Cause Mortality in the ETHOS Trial of Budesonide\/Glycopyrrolate\/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. Am J Respir Crit Care Med. 2021;203(5):553\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3672_CR23","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.3390\/ijms23095066","volume":"23","author":"A Sibille","year":"2022","unstructured":"Sibille A, Corhay JL, Louis R, Ninane V, Jerusalem G, Duysinx B. Eosinophils and Lung Cancer: From Bench to Bedside. Int J Mol Sci. 2022;23(9):5066.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3672_CR24","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/cells9112516","volume":"9","author":"J Kaes","year":"2020","unstructured":"Kaes J, Van der Borght E, Vanstapel A, Van Herck A, Sacreas A, Heigl T, et al. Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation. Cells. 2020;9(11):2516.","journal-title":"Cells"},{"issue":"5","key":"3672_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clinimag.2015.05.013","volume":"39","author":"JA Rotman","year":"2015","unstructured":"Rotman JA, Plodkowski AJ, Hayes SA, de Groot PM, Shepard JAO, Munden RF, et al. Postoperative complications after thoracic surgery for lung cancer. Clin Imaging. 2015;39(5):735\u201349.","journal-title":"Clin Imaging"},{"key":"3672_CR26","unstructured":"World Health Organization. ICD-10: International statistical classification of diseases and related health problems : tenth revision. 2nd ed 2004."},{"issue":"4","key":"3672_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/ejcts\/ezy345","volume":"55","author":"K Konstantinidis","year":"2019","unstructured":"Konstantinidis K, Woodcock-Shaw J, Dinesh P, Brunelli A. Incidence and risk factors for 90-day hospital readmission following video-assisted thoracoscopic anatomical lung resection\u2020. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2019;55(4):666\u201372.","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"3672_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/5584_2021_640","volume":"1347","author":"M Folci","year":"2021","unstructured":"Folci M, Ramponi G, Arcari I, Zumbo A, Brunetta E. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond. Adv Exp Med Biol. 2021;1347:197\u2013219.","journal-title":"Adv Exp Med Biol"},{"key":"3672_CR29","doi-asserted-by":"publisher","first-page":"1119564","DOI":"10.3389\/fimmu.2023.1119564","volume":"14","author":"I Gopallawa","year":"2023","unstructured":"Gopallawa I, Dehinwal R, Bhatia V, Gujar V, Chirmule N. A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention. Front Immunol. 2023;14:1119564.","journal-title":"Front Immunol"},{"key":"3672_CR30","first-page":"1","volume":"2","author":"B Moldoveanu","year":"2009","unstructured":"Moldoveanu B, Otmishi P, Jani P, Walker J, Sarmiento X, Guardiola J, et al. Inflammatory mechanisms in the lung. J Inflamm Res. 2009;2:1\u201311.","journal-title":"J Inflamm Res"},{"issue":"12","key":"3672_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","volume":"5","author":"AT Hastie","year":"2017","unstructured":"Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956\u201367.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3672_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","volume":"150","author":"M Bafadhel","year":"2016","unstructured":"Bafadhel M, Greening NJ, Harvey-Dunstan TC, Williams JEA, Morgan MD, Brightling CE, et al. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. Chest. 2016;150(2):320\u20138.","journal-title":"Chest"},{"key":"3672_CR33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/COPD.S100338","volume":"11","author":"NA Negewo","year":"2016","unstructured":"Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495\u2013504.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"3672_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1183\/09031936.00062614","volume":"44","author":"M Bafadhel","year":"2014","unstructured":"Bafadhel M, Davies L, Calverley PMA, Aaron SD, Brightling CE, Pavord ID. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J. 2014;44(3):789\u201391.","journal-title":"Eur Respir J"},{"issue":"5","key":"3672_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"3","key":"3672_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ciresp.2018.11.005","volume":"97","author":"J Garc\u00eda-Tirado","year":"2019","unstructured":"Garc\u00eda-Tirado J, J\u00fadez-Legaristi D, Landa-Oviedo HS, Miguelena-Bobadilla JM. Unplanned readmission after lung resection surgery: A systematic review. Cir Esp. 2019;97(3):128\u201344.","journal-title":"Cir Esp"},{"issue":"5","key":"3672_CR37","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jtcvs.2014.04.026","volume":"148","author":"Y Hu","year":"2014","unstructured":"Hu Y, McMurry TL, Isbell JM, Stukenborg GJ, Kozower BD. Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality. J Thorac Cardiovasc Surg. 2014;148(5):2261\u2013e22671.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"3672_CR38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jtcvs.2015.08.071","volume":"150","author":"Y Hu","year":"2015","unstructured":"Hu Y, McMurry TL, Stukenborg GJ, Kozower BD. Readmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes. J Thorac Cardiovasc Surg. 2015;150(5):1254\u201360.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"3672_CR39","first-page":"CD012020","volume":"9","author":"C Granger","year":"2022","unstructured":"Granger C, Cavalheri V. Preoperative exercise training for people with non-small cell lung cancer. Cochrane Database Syst Rev. 2022;9(9):CD012020.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3672_CR40","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.athoracsur.2017.08.047","volume":"104","author":"R Bhagat","year":"2017","unstructured":"Bhagat R, Bronsert MR, Ward AN, Martin J, Juarez-Colunga E, Glebova NO, et al. National Analysis of Unplanned Readmissions After Thoracoscopic Versus Open Lung Cancer Resection. Ann Thorac Surg. 2017;104(6):1782\u201390.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3672_CR41","first-page":"453","volume":"14","author":"BS Hendriksen","year":"2019","unstructured":"Hendriksen BS, Reed MF, Taylor MD, Hollenbeak CS. Readmissions After Lobectomy in an Era of Increasing Minimally Invasive Surgery: A Statewide Analysis. Innov Phila Pa. 2019;14(5):453\u201362.","journal-title":"Innov Phila Pa"},{"issue":"11","key":"3672_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","volume":"67","author":"S Suissa","year":"2012","unstructured":"Suissa S, Dell\u2019Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957\u201363.","journal-title":"Thorax"},{"issue":"2","key":"3672_CR43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.athoracsur.2015.10.001","volume":"101","author":"BM Stiles","year":"2016","unstructured":"Stiles BM, Poon A, Giambrone GP, Gaber-Baylis LK, Wu X, Lee PC, et al. Incidence and Factors Associated With Hospital Readmission After Pulmonary Lobectomy. Ann Thorac Surg. 2016;101(2):434\u201342. diacussion 442\u2013443.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3672_CR44","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.chest.2024.08.036","volume":"166","author":"SD Aaron","year":"2024","unstructured":"Aaron SD. COPD Exacerbations and Future Risk of Serious Cardiovascular Events. Chest. 2024;166(6):1262\u20133.","journal-title":"Chest"},{"issue":"6","key":"3672_CR45","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chest.2024.07.150","volume":"166","author":"O Wallstr\u00f6m","year":"2024","unstructured":"Wallstr\u00f6m O, Stridsman C, Lindberg A, Nyberg F, Vanfleteren LEGW. Exacerbation History and Risk of Myocardial Infarction and Pulmonary Embolism in COPD. Chest. 2024;166(6):1347\u201359.","journal-title":"Chest"},{"issue":"1","key":"3672_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","volume":"198","author":"KM Kunisaki","year":"2018","unstructured":"Kunisaki KM, Dransfield MT, Anderson JA, Brook RD, Calverley PMA, Celli BR, et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018;198(1):51\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3672_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.athoracsur.2014.10.014","volume":"99","author":"R Assi","year":"2015","unstructured":"Assi R, Wong DJ, Boffa DJ, Detterbeck FC, Wang Z, Chupp GL, et al. Hospital readmission after pulmonary lobectomy is not affected by surgical approach. Ann Thorac Surg. 2015;99(2):393\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"3672_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.6004\/jnccn.2015.0023","volume":"13","author":"J Klapper","year":"2015","unstructured":"Klapper J, D\u2019Amico TA. VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach. J Natl Compr Cancer Netw JNCCN. 2015;13(2):162\u20134.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"1","key":"3672_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.chest.2022.07.015","volume":"163","author":"H Chen","year":"2023","unstructured":"Chen H, Deng ZX, Sun J, Huang Q, Huang L, He YH, et al. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials. Chest. 2023;163(1):100\u201314.","journal-title":"Chest"},{"issue":"6","key":"3672_CR50","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ejcts.2010.09.025","volume":"39","author":"S B\u00f6l\u00fckbas","year":"2011","unstructured":"B\u00f6l\u00fckbas S, Eberlein M, Eckhoff J, Schirren J. Short-term effects of inhalative tiotropium\/formoterol\/budenoside versus tiotropium\/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2011;39(6):995\u20131000.","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"issue":"4","key":"3672_CR51","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.21037\/jtd-22-1704","volume":"15","author":"T Homma","year":"2023","unstructured":"Homma T. Preoperative umeclidinium\/vilanterol or tiotropium improves postoperative FEV1 in lung cancer patients with comorbid untreated chronic obstructive pulmonary disease. J Thorac Dis. 2023;15(4):1584\u201394.","journal-title":"J Thorac Dis"},{"issue":"9","key":"3672_CR52","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","volume":"7","author":"S Pascoe","year":"2019","unstructured":"Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, et al. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. Lancet Respir Med. 2019;7(9):745\u201356.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"3672_CR53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","volume":"5","author":"M Bafadhel","year":"2017","unstructured":"Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5(9):747\u201359.","journal-title":"Lancet Respir Med"},{"key":"3672_CR54","unstructured":"Ghatak A. Improving lung cancer outcomes: risk prediction of postoperative readmission and assessing the efficacy of smoking cessation interventions. [Internet]. McGill; 2022. Available from: https:\/\/escholarship.mcgill.ca\/concern\/theses\/bn999c83d."},{"key":"3672_CR55","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1749-8090-8-220","volume":"8","author":"R Wotton","year":"2013","unstructured":"Wotton R, Marshall A, Kerr A, Bishay E, Kalkat M, Rajesh P, et al. Does the revised cardiac risk index predict cardiac complications following elective lung resection? J Cardiothorac Surg. 2013;8:220.","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"3672_CR56","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1183\/09031936.00218111","volume":"40","author":"A Bradley","year":"2012","unstructured":"Bradley A, Marshall A, Abdelaziz M, Hussain K, Agostini P, Bishay E, et al. Thoracoscore fails to predict complications following elective lung resection. Eur Respir J. 2012;40(6):1496\u2013501.","journal-title":"Eur Respir J"},{"issue":"4","key":"3672_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3672_CR58","doi-asserted-by":"publisher","first-page":"2004590","DOI":"10.1183\/13993003.04590-2020","volume":"59","author":"VS Benson","year":"2022","unstructured":"Benson VS, Hartl S, Barnes N, Galwey N, Van Dyke MK, Kwon N. Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis. Eur Respir J. 2022;59(1):2004590.","journal-title":"Eur Respir J"},{"issue":"12","key":"3672_CR59","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1513\/AnnalsATS.202010-1249OC","volume":"18","author":"BE Chipps","year":"2021","unstructured":"Chipps BE, Jarjour N, Calhoun WJ, Iqbal A, Haselkorn T, Yang M, et al. A Comprehensive Analysis of the Stability of Blood Eosinophil Levels. Ann Am Thorac Soc. 2021;18(12):1978\u201387.","journal-title":"Ann Am Thorac Soc"},{"key":"3672_CR60","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2147\/COPD.S258353","volume":"15","author":"JK Yoon","year":"2020","unstructured":"Yoon JK, Lee JK, Lee CH, Hwang YI, Kim H, Park D, et al. The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients. Int J Chron Obstruct Pulmon Dis. 2020;15:2061\u201370.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03672-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03672-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03672-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:27:12Z","timestamp":1782192432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03672-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3672"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03672-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Board of the McGill University Health Centre (2021-6528-MUHC) and by the Research Ethics Board of the Tel-Aviv Sourasky Medical Center (0286-24-TLV). Informed consent was waived due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AB reports grants, consulting fees and honoraria for lectures and presentations from AstraZeneca, Sanofi-Regeneron, GSK Kamada Ltd, Boehringer Ingelheim Ltd, and Roche. BS reports institutional grants from the Canadian Institutes of Health Research, National Institutes of Health, Fonds de Recherche du Qu\u00e9bec en Sant\u00e9, and McGill University Health Centre Foundation. NE reports institutional grants from the Canadian Institutes for Health Research, Fonds de Recherche du Qu\u00e9bec en Sant\u00e9, Fonds Innovation Propulsion Sant\u00e9 - Minist\u00e8re de la Sant\u00e9 et des Services Sociaux Quebec, Accelerating Clinical Trials Network; honoraria for lectures and presentations from AstraZeneca, GSK, and the Canadian Thoracic Society. Other co-authors EM, OF, IP, AG, CR, SJ, JRS, SK report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}